Avalo Therapeutics, Inc. (AVTX) develops antibody treatments for inflammatory diseases. In my view, Abdakibart is their lead candidate and targets hidradenitis suppurativa (HS). AVTX recently reported positive Phase 2 results for Abdakibart with
CryptoAlerta — análise de criptomoedas e mercado em tempo real